People

Chris Nave

Chris Nave is founding partner & managing director at Brandon Capital. He also leads Brandon BioCatalyst as CEO. Earlier roles included commercialisation leadership at Baker IDI, biotechnology management at Melbourne Ventures, Uniseed investing and pharmaceutical business development at Leiras. His research training at Melbourne encompasses an honours science degree and an endocrinology/physiology doctorate. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.